The 31-gene expression profile test informs sentinel lymph node biopsy decisions in patients with cutaneous melanoma: results of a prospective, multicenter study

M Yamamoto, B Sickle-Santanello, T Beard… - Current Medical …, 2023 - Taylor & Francis
Background The 31-gene expression profile test (Class 1A: low-risk; 1B/2A: intermediate-
risk; 2B: high-risk) is validated to identify patients with cutaneous melanoma who can safely …

A retrospective study of sentinel lymph node biopsy for skin cancer in Japan: Comparison with breast cancer and evaluation of factors related to its use

S Wada, T Watanabe, T Ishii, Y Ichinose… - Cancer …, 2023 - Wiley Online Library
Background Sentinel lymph node biopsy (SLNB) underuse has been reported for skin
cancers; however, actual performance rates have not been compared. The objective of this …

Impact of extra-nodal extension and AJCC lymph node staging in predicting recurrence following lymphadenectomy in patients with melanoma

J Downey, J Hamm, C Baliski - The American Journal of Surgery, 2024 - Elsevier
Background Regional lymphadenectomy (RL) has traditionally been recommended in
patients with melanoma found to have clinical lymphadenopathy or a positive sentinel lymph …

[HTML][HTML] Diagnostic biopsy of cutaneous melanoma, sentinel lymph node biopsy and indications for lymphadenectomy

ET Pavlidis, TE Pavlidis - World Journal of Clinical Oncology, 2022 - ncbi.nlm.nih.gov
The incidence of cutaneous melanoma appears to be increasing worldwide and this is
attributed to solar radiation exposure. Early diagnosis is a challenging task. Any clinically …